Brief: Stayble Therapeutics Q3 EBIT Loss SEK 2.3 Mln
29/11/2024 07:36
Nov 29 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q3 EBIT AMOUNTED TO KSEK -2 339
* Q3 NET LOSS FOR THE PERIOD AMOUNTED TO KSEK -2 335
Source text: ID:nWkr574BhF
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln